Division of Nuclear Medicine, Department of Radiology, Kansas University Medical Center, MS 4032, 3901 Rainbow Boulevard, Kansas City, KS 66160-7234, USA.
This article provides an overview of imaging modalities that aid in diagnosing, staging, and assessing therapeutic response in prostate cancer. Prostate cancer is the second most common type of cancer in American men and the second leading cause of cancer death among men. Prostate cancer is difficult to diagnose in early stages, and advanced disease often recurs after treatment. To localize sites of recurrence many imaging modalities have been used with varying success. This article presents case studies of PET scanning using carbon 11 acetate and discusses intravenously infused ascorbate, a complementary and alternative medicine therapy for prostate cancer.
Written by:
Dusing RW, Drisko JA, Grado GG, Levine M, Holzbeierlein JM, Van Veldhuizen P. Are you the author?
Reference: Urol Clin North Am. 2011 Aug;38(3):343-57.
doi: 10.1016/j.ucl.2011.04.003
PubMed Abstract
PMID: 21798397
UroToday.com Prostate Cancer Section
